1
|
Lusis AJ: Atherosclerosis. Nature.
407:233–241. 2000. View
Article : Google Scholar : PubMed/NCBI
|
2
|
Hansson GK, Libby P and Tabas I:
Inflammation and plaque vulnerability. J Intern Med. 278:483–493.
2015. View Article : Google Scholar : PubMed/NCBI
|
3
|
Libby P and Hansson GK: Inflammation and
immunity in diseases of the arterial tree: Players and layers. Circ
Res. 116:307–311. 2015. View Article : Google Scholar : PubMed/NCBI
|
4
|
Tabas I, García-Cardeña G and Owens GK:
Recent insights into the cellular biology of atherosclerosis. J
Cell Biol. 209:13–22. 2015. View Article : Google Scholar : PubMed/NCBI
|
5
|
Mudau M, Genis A, Lochner A and Strijdom
H: Endothelial dysfunction: The early predictor of atherosclerosis.
Cardiovasc J Afr. 23:222–231. 2012. View Article : Google Scholar : PubMed/NCBI
|
6
|
Thum T and Mayr M: Review focus on the
role of microRNA in cardiovascular biology and disease. Cardiovasc
Res. 93:543–544. 2012. View Article : Google Scholar : PubMed/NCBI
|
7
|
Winter J, Jung S, Keller S, Gregory RI and
Diederichs S: Many roads to maturity: MicroRNA biogenesis pathways
and their regulation. Nat Cell Biol. 11:228–234. 2009. View Article : Google Scholar : PubMed/NCBI
|
8
|
Natarelli L and Schober A: MicroRNAs and
the response to injury in atherosclerosis. Hamostaseologie.
35:142–150. 2015. View Article : Google Scholar : PubMed/NCBI
|
9
|
Hwang HW and Mendell JT: MicroRNAs in cell
proliferation, cell death, and tumorigenesis. Br J Cancer.
96:776–780. 2006. View Article : Google Scholar
|
10
|
Matsushita R, Seki N, Chiyomaru T,
Inoguchi S, Ishihara T, Goto Y, Nishikawa R, Mataki H, Tatarano S,
Itesako T, et al: Tumour-suppressive microRNA-144-5p directly
targets CCNE1/2 as potential prognostic markers in bladder cancer.
Br J Cancer. 113:282–289. 2015. View Article : Google Scholar : PubMed/NCBI
|
11
|
Song L, Peng L, Hua S, Li X, Ma L, Jie J,
Chen D, Wang Y and Li D: miR-144-5p enhances the radiosensitivity
of non-small-cell lung cancer cells via targeting ATF2. Biomed Res
Int. 2018:51094972018. View Article : Google Scholar : PubMed/NCBI
|
12
|
Ji R, Cheng Y, Yue J, Yue J, Yang J, Liu
X, Chen H, Dean DB and Zhang C: MicroRNA expression signature and
antisense-mediated depletion reveal an essential role of microRNA
in vascular neointimal lesion formation. Circ Res. 100:1579–1588.
2007. View Article : Google Scholar : PubMed/NCBI
|
13
|
Shan Z, Yao C, Li ZL, Teng Y, Li W, Wang
JS, Ye CS, Chang GQ, Huang XL, Li XX, et al: Differentially
expressed microRNAs at different stages of atherosclerosis in
ApoE-deficient mice. Chin Med J (Engl). 126:515–520.
2013.PubMed/NCBI
|
14
|
Hosin AA, Prasad A, Viiri LE, Davies AH
and Shalhoub J: MicroRNAs in atherosclerosis. J Vasc Res.
51:338–349. 2014. View Article : Google Scholar : PubMed/NCBI
|
15
|
Alexandru N, Badila E, Weiss E, Cochior D,
Stępień E and Georgescu A: Vascular complications in diabetes:
Microparticles and microparticle associated microRNAs as active
players. Biochem Biophys Res Commun. 472:1–10. 2016. View Article : Google Scholar : PubMed/NCBI
|
16
|
Kumar S, Kim CW, Simmons RD and Jo H: Role
of flow-sensitive microRNAs in endothelial dysfunction and
atherosclerosis: Mechanosensitive athero-miRs. Arterioscler Thromb
Vasc Biol. 34:2206–2216. 2014. View Article : Google Scholar : PubMed/NCBI
|
17
|
Sun X, Belkin N and Feinberg MW:
Endothelial microRNAs and atherosclerosis. Curr Atheroscler Rep.
15:3722013. View Article : Google Scholar : PubMed/NCBI
|
18
|
Guo Y, Ying L, Tian Y, Yang P, Zhu Y, Wang
Z, Qiu F and Lin J: miR-144 downregulation increases bladder cancer
cell proliferation by targeting EZH2 and regulating Wnt signaling.
FEBS J. 280:4531–4538. 2013. View Article : Google Scholar : PubMed/NCBI
|
19
|
Guan H, Liang W, Xie Z, Li H, Liu J, Liu
L, Xiu L and Li Y: Down-regulation of miR-144 promotes thyroid
cancer cell invasion by targeting ZEB1 and ZEB2. Endocrine.
48:566–574. 2015. View Article : Google Scholar : PubMed/NCBI
|
20
|
Liu J, Xue H, Zhang J, Suo T, Xiang Y,
Zhang W, Ma J, Cai D and Gu X: MicroRNA-144 inhibits the metastasis
of gastric cancer by targeting MET expression. J Exp Clin Cancer
Res. 34:352015. View Article : Google Scholar : PubMed/NCBI
|
21
|
Iwaya T, Yokobori T, Nishidan N, Kogo R,
Sudo T, Tanaka F, Shibata K, Sawada G, Takahashi Y, Ishibashi M, et
al: Downregulation of miR-144 is associated with colorectal cancer
progression via activation of mTOR signaling pathway.
Carcinogenesis. 33:2391–2397. 2012. View Article : Google Scholar : PubMed/NCBI
|
22
|
Han S, Zhu J and Zhang Y: miR-144
potentially suppresses proliferation and migration of ovarian
cancer cells by targeting RUNX1. Med Sci Monit Basic Res. 24:46.
2018. View Article : Google Scholar
|
23
|
Zhang LY, Ho-Fun Lee V, Wong AM, Kwong DL,
Zhu YH, Dong SS, Kong KL, Chen J, Tsao SW, Guan XY and Fu L:
MicroRNA-144 promotes cell proliferation, migration and invasion in
nasopharyngeal carcinoma through repression of PTEN.
Carcinogenesis. 34:454–463. 2013. View Article : Google Scholar : PubMed/NCBI
|
24
|
Ren K, Liu QQ, An ZF, Zhang DP and Chen
XH: miR-144 functions as tumor suppressor by targeting PIM1 in
gastric cancer. Eur Rev Med Pharmacol Sci. 21:3028–3037.
2017.PubMed/NCBI
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
26
|
Alvarez RJ, Gips SJ, Moldovan N, Wilhide
CC, Milliken EE, Hoang AT, Hruban RH, Silverman HS, Dang CV and
Goldschmidt-Clermont PJ: 17beta-estradiol inhibits apoptosis of
endothelial cells. Biochem Biophys Res Commun. 237:372–381. 1997.
View Article : Google Scholar : PubMed/NCBI
|
27
|
Wu Q, Jin H, Yang Z, Luo G, Lu Y, Li K,
Ren G, Su T, Pan Y, Feng B, et al: miR-150 promotes gastric cancer
proliferation by negatively regulating the pro-apoptotic gene EGR2.
Biochem Biophys Res Commun. 392:340–345. 2010. View Article : Google Scholar : PubMed/NCBI
|
28
|
Bou Kheir T, Futoma-Kazmierczak E,
Jacobsen A, Krogh A, Bardram L, Hother C, Grønbæk K, Federspiel B,
Lund AH and Friis-Hansen L: miR-449 inhibits cell proliferation and
is down-regulated in gastric cancer. Mol Cancer. 10:292011.
View Article : Google Scholar : PubMed/NCBI
|
29
|
Kogo R, Mimori K, Tanaka F, Komune S and
Mori M: Clinical signifcance of miR-146a in gastric cancer cases.
Clin Cancer Res. 17:4277–4284. 2011. View Article : Google Scholar : PubMed/NCBI
|
30
|
Tsai KW, Wu CW, Hu LY, Li SC, Liao YL, Lai
CH, Kao HW, Fang WL, Huang KH, Chan WC and Lin WC: Epigenetic
regulation of miR-34b and miR-129 expression in gastric cancer. Int
J Cancer. 129:2600–2610. 2011. View Article : Google Scholar : PubMed/NCBI
|
31
|
Bai M, Li J, Yang H, Zhang H, Zhou Z, Deng
T, Zhu K, Ning T, Fan Q, Ying G and Ba Y: miR-135b delivered by
gastric tumor exosomes inhibits FOXO1 expression in endothelial
cells and promotes angiogenesis. Mol Ther. 27:1772–1783. 2019.
View Article : Google Scholar : PubMed/NCBI
|
32
|
Zheng B, Yin WN, Suzuki T, Zhang XH, Zhang
Y, Song LL, Jin LS, Zhan H, Zhang H, Li JS and Wen JK:
Exosome-mediated miR-155 transfer from smooth muscle cells to
endothelial cells induces endothelial injury and promotes
atherosclerosis. Mol Ther. 25:1279–1294. 2017. View Article : Google Scholar : PubMed/NCBI
|
33
|
Gao Y, Peng J, Ren Z, He NY, Li Q, Zhao
XS, Wang MM, Wen HY, Tang ZH, Jiang ZS, et al: Functional
regulatory roles of microRNAs in atherosclerosis. Clin Chim Acta.
460:164–171. 2016. View Article : Google Scholar : PubMed/NCBI
|
34
|
Yamada Y, Arai T, Kojima S, Sugawara S,
Kato M, Okato A, Yamazaki K, Naya Y, Ichikawa T and Seki N:
Regulation of antitumor miR-144-5p targets oncogenes: Direct
regulation of syndecan-3 and its clinical significance. Cancer Sci.
109:2919–2936. 2018. View Article : Google Scholar : PubMed/NCBI
|
35
|
Li J, Wang R, Ge Y, Chen D, Wu B and Fang
F: Assessment of microRNA-144-5p and its putative targets in
inflamed gingiva from chronic periodontitis patients. J Periodontal
Res. 54:266–277. 2019. View Article : Google Scholar : PubMed/NCBI
|
36
|
Wang X, Sundquist K, Hedelius A, Palmér K,
Memon AA and Sundquist J: Circulating microRNA-144-5p is associated
with depressive disorders. Clin Epigenetics. 7:692015. View Article : Google Scholar : PubMed/NCBI
|
37
|
Zou Z, Chen J, Yang J and Bai X: Targeted
inhibition of rictor/mTORC2 in cancer treatment: A new era after
rapamycin. Curr Cancer Drug Targets. 16:288–304. 2016. View Article : Google Scholar : PubMed/NCBI
|
38
|
Heiss C, Rodriguez-Mateos A and Kelm M:
Central role of eNOS in the maintenance of endothelial homeostasis.
Antioxid Redox Signal. 22:1230–1242. 2015. View Article : Google Scholar : PubMed/NCBI
|
39
|
Qin B, Shu Y, Long L, Li H, Men X, Feng L,
Yang H and Lu Z: MicroRNA-142-3p induces atherosclerosis-associated
endothelial cell apoptosis by directly targeting rictor. Cell
Physiol Biochem. 47:1589–1603. 2018. View Article : Google Scholar : PubMed/NCBI
|